- Home
- RPRX vs ACI Comparison
RPRX vs ACI Comparison
Compare RPRX & ACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- ACI
- Stock Information
- Founded
- RPRX 1996
- ACI 1860
- Country
- RPRX United States
- ACI United States
- Employees
- RPRX N/A
- ACI N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- ACI Food Chains
- Sector
- RPRX Health Care
- ACI Consumer Staples
- Exchange
- RPRX Nasdaq
- ACI Nasdaq
- Market Cap
- RPRX 14.2B
- ACI 12.2B
- IPO Year
- RPRX 2020
- ACI 2020
- Fundamental
- Price
- RPRX $31.28
- ACI $22.43
- Analyst Decision
- RPRX Strong Buy
- ACI Buy
- Analyst Count
- RPRX 5
- ACI 12
- Target Price
- RPRX $41.60
- ACI $23.85
- AVG Volume (30 Days)
- RPRX 4.5M
- ACI 8.5M
- Earning Date
- RPRX 05-08-2025
- ACI 04-15-2025
- Dividend Yield
- RPRX 2.81%
- ACI 2.67%
- EPS Growth
- RPRX N/A
- ACI N/A
- EPS
- RPRX 1.91
- ACI 1.78
- Revenue
- RPRX $2,263,576,000.00
- ACI $79,930,900,000.00
- Revenue This Year
- RPRX $34.04
- ACI $2.35
- Revenue Next Year
- RPRX $6.10
- ACI $2.44
- P/E Ratio
- RPRX $16.36
- ACI $12.61
- Revenue Growth
- RPRX N/A
- ACI 0.97
- 52 Week Low
- RPRX $24.05
- ACI $17.00
- 52 Week High
- RPRX $34.20
- ACI $22.59
- Technical
- Relative Strength Index (RSI)
- RPRX 35.96
- ACI 64.97
- Support Level
- RPRX $30.64
- ACI $20.66
- Resistance Level
- RPRX $31.51
- ACI $22.05
- Average True Range (ATR)
- RPRX 0.74
- ACI 0.45
- MACD
- RPRX -0.31
- ACI 0.10
- Stochastic Oscillator
- RPRX 18.29
- ACI 91.95
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About ACI Albertsons Companies Inc.
Albertsons is the second largest supermarket operator in the United States with more than 2,200 stores across a variety of banners. About 80% of the firm's sales stem from non-perishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers and pharmacies at about 20% and 75% of its store locations, respectively. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of outstanding shares.